Molecular biology of esophageal cancer in the genomics era

Surgical Clinics of North America

Volumn 85, Issue 3, 2005, Pages 539-553

  Kwong, King F ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; GLYCOPROTEIN;

APOPTOSIS; CANCER SURVIVAL; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; DNA MICROARRAY; DNA REPLICATION; ESOPHAGUS CANCER; GENE MUTATION; GENOMICS; HUMAN; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEOMICS; RETINOBLASTOMA; REVIEW; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; APOPTOSIS; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; GENOMICS; HUMANS; MOLECULAR BIOLOGY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOMICS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 20344406223     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2005.01.004     Document Type: Review

References (94)

1. A. Jemel, T. Murray, and A. Samuels Cancer statistics, 2003 CA Cancer J Clin 53 2003 5 26
2. Cancer Facts & Figures. Atlanta (GA): American Cancer Society; 2003.
3. H.B. El-Serag The epidemic of esophageal carcinoma Gastroenterol Clin N Am 31 2002 421 440
4. P.C. Yang, and S. Davis Incidence of cancer of the esophagus in the US by histologic type Cancer 61 1988 612 617
5. W.J. Blot, S.S. Devesa, and R.W. Kneller Rising incidence of adenocarcinoma of the esophagus and gastric cardia JAMA 265 1991 1287 1289
6. W.J. Blot, S.S. Devesa, and J.F. Fraumeni Continuing climb in rates of esophageal adenocarcinoma: an update JAMA 270 1993 1320
7. M. Pera, A.J. Cameron, and V.F. Trastek Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction Gastroenterology 104 1993 510 513
8. P.I. Reed, and B.J. Johnston The changing incidence of oesophageal cancer Endoscopy 25 1993 606 608
9. J.M. Daly, L.H. Karnell, and H.R. Menck National cancer database report on esophageal carcinoma Cancer 78 1996 1820 1828
10. R.F. Heitmiller, and R.R. Sharma Comparison of prevalence and resection rates in patients with esophageal squamous cell carcinoma and adenocarcinoma J Thorac Cardiovasc Surg 112 1996 130 136
11. M. Younes, D.E. Henson, and A. Ertan Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type Scand J Gastroenterol 37 2002 1359 1365
12. J. Powell, C.C. McConkey, and E.W. Gillison Continuing rising trend in oesophageal adenocarcinoma Int J Cancer 102 2002 422 427
13. C. Walther, T. Zilling, and R. Perfekt Increasing prevalence of adenocarcinoma of the oesophagus and gastro-oesophageal junction: a study of the Swedish population between 1970 and 1997 Eur J Surg 167 2001 748 757
14. D.A. Corley, and P.A. Buffler Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database Int J Epidemiol 30 2001 1415 1425
15. L. Ke Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-1990 Int J Cancer 102 2002 271 274
16. S.S. Chang, C.L. Lu, and J.Y. Chao Unchanging trend of adenocarcinoma of the esophagus and gastric cardia in Taiwan: a 15-year experience in a single center Dig Dis Sci 47 4 2002 735 740
17. S. Law, and J. Wong Changing disease burden and management issues for esophageal cancer in the Asia-Pacific region J Gastroenterol Hepatol 17 2002 374 381
18. N. Shaheen, and D.F. Ransohoff Gastroesophageal reflux, Barrett esophagus, and esophageal cancer JAMA 287 15 2002 1972 1981
19. L. Murray, P. Watson, and B. Johnston Risk of adenocarcinoma in Barrett's oesophagus: population-based study BMJ 327 2003 534 535
20. L.A. Anderson, L.J. Murray, and S.J. Murphy Mortality in Barrett's oesophagus: results from a population-based study Gut 52 2003 1081 1084
21. R.C. Heading Barrett's oesophagus: epidemiology comes up with a surprise Gut 52 2003 1079 1080
22. S.J. Spechler Screening for Barrett's esophagus Rev Gastroenterol Disord 2 Suppl 2 2002 S25 S29
23. N. Shaheen Is there a "Barrett's iceberg?" Gastroenterology 123 2 2002 636 637
24. L.B. Gerson, K. Shetler, and G. Triadafilopoulos Prevalence of Barrett's esophagus in asymptomatic individuals Gastroenterology 123 2002 461 467
25. D.A. Corley, T.R. Levin, and L.A. Habel Surveillance and survival in Barrett's adenocarcinomas: a population-based study Gastroenterology 122 2002 633 640
26. G.S. Dulai, S. Guha, and K.L. Kahn Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review Gastroenterology 122 2002 26 33
27. S.J. Sontag Preventing death of Barrett's cancer: does frequent surveillance endoscopy do it? Am J Med 111 Suppl 8A 2001 137S 141S
28. N.J. Shaheen, M.A. Crosby, and E.M. Bozymski Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 119 2000 333 338
29. D.G. Colin-Jones, M.J.S. Langman, and D.H. Lawson Post-marketing surveillance of the safety of cimetidine: 12 month mortality report BMJ 286 1983 1713 1716
30. D.G. Colin-Jones, M.J.S. Langman, and D.H. Lawson Post-marketing surveillance of the safety of cimetidine: mortality during second, third, and fourth year of follow-up BMJ 291 1985 1084 1088
31. D.G. Colin-Jones, M.J.S. Langman, and D.H. Lawson Post-marketing surveillance of the safety of cimetidine: 10 year mortality report Gut 33 1992 1280 1284
32. D.N. Bateman, D. Colin-Jones, and S. Hartz Mortality study of 18,000 patients treated with omeprazole Gut 52 2003 942 946
33. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
34. P.S. Sirieix, M. O'Donovan, and J. Brown Surface expression of minichromosome maintenance proteins provides a novel method for detecting patients at risk for developing adenocarcinoma in Barrett's esophagus Clin Cancer Res 9 2003 2560 2566
35. J.R. Dunn, J.M. Risk, and J.E. Langan Physical and transcript map of the minimally deleted region III on 17p implicated in the early development of Barrett's oesophageal adenocarcinoma Oncogene 22 2003 4134 4142
36. H. Mork, M. Scheurlen, and O. Al-Taie Glutathione peroxidase isoforms as part of the local antioxidative defense system in normal and Barrett's esophagus Int J Cancer 105 2003 300 304
37. M. Sarris, M. Konopka, and C.S. Lee Differential expression of nm23 protein in the progression of oesophageal adenocarcinoma Pathology 35 2003 37 41
38. M. Marchetti, E. Caliot, and E. Pringault Chronic acid exposure leads to activation of the cdx2 intestinal homeobox gene in a long-term culture of mouse esophageal keratinocytes J Cell Sci 116 2003 1429 1436
39. C. Tselepis, I. Perry, and C. Dawson Tumour necrosis factor-α in Barrett's oesophagus: a potential novel mechanism of action Oncogene 21 2002 6071 6081
40. M.I. Auvinen, E.I. Sihvo, and T. Ruohtula Incipient angiogenesis in Barrett's epithelium and lymphangiogenesis in Barrett's adenocarcinoma J Clin Oncol 20 2002 2971 2979
41. N.S. Buttar, K.K. Wang, and O. Leontovich Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus Gastroenterology 122 2002 1101 1112
42. B.M. Ryan, R. McManus, and J.S. Daly A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma Br J Cancer 85 10 2001 1499 1503
43. W. El-Rifai, H.F. Frierson, and C.A. Moskaluk Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa Gastroenterology 121 2001 592 598
44. J.S. Lee, T.Y. Oh, and B.O. Ahn Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants Mutat Res 2001 Sep 1:189-200
45. J. Brabender, R.V. Lord, and K.D. Danenberg Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma J Surg Res 99 2001 301 306
46. A.P. Weston, S.K. Banerjee, and P. Sharma p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression Am J Gastroenterol 96 2001 1355 1362
47. H.M. Kandil, G. Tanner, and W. Smalley Cyclooxygenase-2 expression in Barrett's esophagus Dig Dis Sci 46 4 2001 785 789
48. M. Sarbia, U. Tekin, and M. Zeriouh Expression of RB protein, allelic imbalance of the RB gene and amplification of the CDK4 gene in metaplasias, dysplasias, and carcinomas in Barrett's esophagus Anticancer Res 21 2001 387 392
49. S. Romagnoli, M. Roncalli, and D. Graziani Molecular alterations of Barrett's esophagus on microdissected endoscopic biopsies Lab Invest 81 2 2001 241 247
50. J.R. Dunn, J. Garde, and K. Dolan The evolution of loss of heterozygosity on chromosome 17 during the progression to Barrett's adenocarcinoma involves a unique combination of target sites in individual specimens Clin Cancer Res 6 2000 4033 4042
51. T.A. Woodward, P.D. Klingler, and P.V. Genko Barrett's esophagus, apoptosis, and cell cycle regulation: correlation of p53, Bax, Bcl-2, and p21 protein expression Anticancer Res 20 2000 2427 2432
52. R.V.N. Lord, R.O. O'Grady, and C. Sheehan K-ras codon 12 mutations in Barrett's oesophagus and adenocarcinomas of the oesophagus and oesophagogastric junction J Gastroenterol Hepatol 15 2000 730 736
53. K. Dolan, J. Garde, and S.J. Walker LOH at the sites of the DCC, APC, and TP53 tumor suppressor genes occurs in Barrett's metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus Hum Pathol 30 1999 1508 1514
54. E.M. van Lieshout, U.J. van Haelst, and T. Wobbes Immunohistochemical localization of glutathione S-transferase α and π in human esophageal squamous epithelium, Barrett's epithelium and carcinoma Jpn J Cancer Res 90 1999 530 535
55. M. Fein, J.H. Peters, and N. Baril Loss of function of Trp53, but not Apc, leads to the development of esophageal adenocarcinoma in mice with jejunoesophageal reflux J Surg Res 83 1999 48 55
56. O.S. Soldes, R.D. Kuick, and Thompson II Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas Br J Cancer 79 1999 595 603
57. E.M. van Lieshout, H.M. Roelofs, and S. Dekker Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma Cancer Res 59 1999 586 589
58. C.P. Morales, E.L. Lee, and J.W. Shay In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma Cancer 83 1998 652 659
59. D. Michael, D.G. Beer, and C.W. Wilker Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas Oncogene 15 1997 1653 1659
60. M.C. Palanca-Wessels, M.T. Barrett, and P.C. Galipeau Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities Gastroenterology 114 1998 295 304
61. M. Younes, A. Ertan, and L.V. Lechago p53 protein accumulation is a specific marker of malignant potential in Barrett's metaplasia Dig Dis Sci 42 4 1997 697 701
62. S. Kumble, M.B. Omary, and C.A. Cartwright Src activation in malignant and premalignant epithelia of Barrett's esophagus Gastroenterology 112 1997 348 356
63. M.T. Barrett, C.A. Sanchez, and P.C. Galipeau Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus Oncogene 13 1996 1867 1873
64. 2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus Proc Natl Acad Sci USA 93 1996 7081 7084
65. P.M. Schneider, A.G. Casson, and B. Levin Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases J Thorac Cardiovasc Surg 111 1996 323 333
66. C.M. Gleeson, J.M. Sloan, and J.A. McGuigan Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma Cancer Res 55 1995 3406 3411
67. R.H. Hardwick, N.A. Shepherd, and M. Moorghen c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus J Clin Pathol 48 2 1995 129 132
68. Y. Liu, X.H. Wang, and F. Liu Translocation of annexin I from cellular membrane to the nuclear membrane in human esophageal squamous cell carcinoma World J Gastroenterol 9 4 2003 645 649
69. X. Li, J.Y. Lu, and L.Q. Zhao Overexpression of ETS2 in human esophageal squamous cell carcinoma World J Gastroenterol 9 2 2003 205 208
70. Y. Nie, J. Liao, and X. Zhao Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma Carcinogenesis 23 10 2002 1713 1720
71. J. Zhou, H. Wang, and A. Lu A novel gene, NMES1, downregulated in human esophageal squamous cell carcinoma Int J Cancer 101 2002 311 316
72. R. Mathew, S. Arora, and R. Khanna Alterations in p53 and pRb pathways and their prognostic significance in oesophageal cancer Eur J Cancer 38 2002 832 841
73. Q. Wang, J. Lu, and C. Yang CASK and its target gene Reelin were co-upregulated in human esophageal carcinoma Cancer Lett 179 1 2002 71 77
74. K. Nakakuki, I. Imoto, and A. Pimkhaokham Novel targets for the 18p11.3 amplification frequently observed in esophageal squamous cell carcinomas Carcinogenesis 23 1 2002 19 24
75. A. Kitamura, K. Yashima, and E. Okamoto Reduced Fhit expression occurs in the early stage of esophageal tumorigenesis: no correlation with p53 expression and apoptosis Oncology 61 2001 205 211
76. C.P. Paweletz, D.K. Ornstein, and M.J. Roth Loss of annexin I correlates with early onset of tumorigenesis in esophageal and prostate carcinoma Cancer Res 60 2000 6293 6297
77. waf1/cip1 cyclin dependent kinase inhibitor gene: association with human esophageal cancer Oncogene 19 2000 323 328
78. I. Shibagaki, H. Tanaka, and Y. Shimada p53 mutation, Murine DoubleMinute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma Clin Cancer Res 1 1995 769 773
79. W. Gamieldien, T.C. Victor, and D. Mugwanya p53 and p16/CDKN2 gene mutations in esophageal tumors from a high-incidence area in South Africa Int J Cancer 78 1998 544 549
80. A.R. Parenti, M. Rugge, and Y.H. Shiao bcl-2 and p53 immunophenotypes in pre-invasive, early and advanced oesophageal squamous cancer Histopathology 31 1997 430 435
81. I. Shibagaki, I. Shimada, and T. Wagata Allelotype analysis of esophageal squamous cell carcinoma Cancer Res 54 1994 2996 3000
82. Y. Huang, R.F. Boynton, and P.L. Blount Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers Cancer Res 52 1992 6525 6530
83. J. Lu, A. Liu, and M. Xiong Gene expression profile changes in initiation and progression of squamous cell carcinoma of esophagus Int J Cancer 91 2001 288 294
84. Y.C. Hu, K.Y. Lam, and S. Law Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC Clin Cancer Res 7 2001 2213 2221
85. T. Kan, Y. Shimada, and F. Sato Gene expression profiling in human esophageal cancers using cDNA microarray Biochem Biophys Res Commun 286 2001 792 801
86. J. Zhou, L.Q. Zhao, and M.M. Xiong Gene expression profiles at different stages of human esophageal squamous cell carcinoma World J Gastroenterol 9 1 2003 9 15
87. H.T. Wang, J.P. Kong, and F. Ding Analysis of gene expression profile induced by EMP-1 in esophageal cancer cells using cDNA microarray World J Gastroenterol 9 3 2003 392 398
88. S.H. Xu, L.J. Qian, and H.Z. Mou Difference of gene expression profiles between esophageal carcinoma and its precancerous epithelium by gene chip World J Gastroenterol 9 3 2003 417 422
89. H. Zhi, J. Zhang, and G. Hu The deregulation of arachidonic acid metabolism-related genes in human esophageal squamous cell carcinoma Int J Cancer 106 2003 327 333
90. H. Kawamata, T. Furihata, and F. Omotehara Identification of genes differentially expressed in a newly isolated human metastasizing esophageal cancer cell line, T.Tn-AT1, by cDNA microarray Cancer Sci 94 2003 699 706
91. C. Kihara, T. Tsunoda, and T. Tanaka Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles Cancer Res 61 2001 6474 6479
92. F.M. Selaru, T. Zou, and Y. Xu Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays Oncogene 21 2002 475 478
93. Y. Xu, F.M. Selaru, and J. Yin Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer Cancer Res 62 2002 3493 3497
94. L.Y. Zhang, W.T. Ying, and Y.S. Mao Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches World J Gastroenterol 9 4 2003 650 654